Inactivation of the p53 gene is a key driver of tumorigenesis in various cancer cohorts and types.The quest for a successful p53-based therapy that holds the promise of treating more than half of the cancer population...Inactivation of the p53 gene is a key driver of tumorigenesis in various cancer cohorts and types.The quest for a successful p53-based therapy that holds the promise of treating more than half of the cancer population has culminated in extensive knowledge about the role and function of p53 and led to new proposed innovative strategies against p53-defective cancers.We will discuss some of these latest studies with a focus on metabolic regulation and DNA damage response and also highlight novel functions of p53 in these pathways that may provide a contemporary rationale for targeting p53 loss in tumors.展开更多
文摘Inactivation of the p53 gene is a key driver of tumorigenesis in various cancer cohorts and types.The quest for a successful p53-based therapy that holds the promise of treating more than half of the cancer population has culminated in extensive knowledge about the role and function of p53 and led to new proposed innovative strategies against p53-defective cancers.We will discuss some of these latest studies with a focus on metabolic regulation and DNA damage response and also highlight novel functions of p53 in these pathways that may provide a contemporary rationale for targeting p53 loss in tumors.
